ACC Recommendations on the Role of Nonstatin Therapies for Lowering LDL-C
In 2021, an expert panel assembled to review gaps in care related to treatments meant to lower LDL-C in patients with atherosclerotic cardiovascular disease.
Cardiovascular and Metabolic Disorders
Frozen Embryo Transfer Tied to Hypertensive Disorders in Pregnancy
Frozen embryo transfer (ET) is associated with a substantially higher risk for hypertensive disorders in pregnancy.
OAC in Patients With AF and COVID-19 Lowers Rates of Death, Thrombotic Events
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.
High Blood Pressure Tied to 1 in 8 Emergency Visits for Cardiovascular Issues
There are significant sex differences in disease distribution, hospitalization, and death among U.S. ED presentations for cardiovascular encounters.
SGLT-2 Inhibitors Show Benefit in Heart Failure With Preserved Ejection Fraction
Investigators conducted a meta-analysis of randomized controlled trials on the effect of SGLT-2 inhibitors on patients with HFpEF.
ADHD Is Risk Factor for Cardiovascular Diseases
Significant link seen for ADHD with risk for any CVD, especially cardiac arrest, hemorrhagic stroke, peripheral vascular disease/arteriosclerosis
Guidelines for Managing HF in Diabetes, Cardiorenal, and Metabolic Conditions
Practice guidelines have been developed regarding management of patients with heart failure and diabetes, cardiorenal, and/or metabolic conditions.
AHA Statement on the Effects of Loneliness, Isolation on Cardiovascular Health
The AHA assessed existing research on the impact of loneliness and isolation on brain and cardiovascular health.
USPSTF Recommends Statins for Primary Prevention of CVD in Adults
The U.S. Preventive Services Task Force (USPSTF) concludes that people aged 40 to 75 years at high risk for cardiovascular disease (CVD) should receive statins.
Decreased Arrhythmia Burden in High-Risk CVD With Targeted Potassium Levels
Researchers sought to determine if increased plasma potassium concentration decreases risk for malignant arrhythmia in high-risk patients with CVD.
- Loading...
Loading...
Next post in Cardiovascular and Metabolic Disorders
Loading... 
Loading...